Keikyo Haribayashi

EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan.

Part of KPMG International Cooperative, KPMG Japan provides financial and corporate advisory services.

Synectic Research & Analysis, Inc. provides aerospace engineering, technology research, and development services. It supports the Missile Defense Agency (MDA), the Space and Missile Defense Command (SMDC), and the National Air and Space Intelligence Center (NASIC) with test planning, modeling, simulation, target design and characterization, and test data analysis. The company was founded in 2001 and is headquartered in Huntsville, AL.

EPS China Co., Ltd. engages in the research, development, manufacture, and sales of medical devices, pharmaceuticals, and research equipment. It operates through the following businesses: Pharmaceutical, Medical Instrument, Contract Research Organization Plus (CRO+) Professional Services, International Trade, Investment, and EPS Plus Supporting. The Pharmaceutical business builds a complete industrial chain of pharmaceutical products from research and development to sales. The Medical Instrument business sells medical equipment and consumables, and provides after-sales services. The CRO+ Professional Services business provides clinical trial services and builds medical service platform. The International Trade business offers equipment and materials for pharmacological research and other preclinical trials, as well as provides professional services for new drug development. The Investment business provides financial support for companies and research projects through direct investment and funds. The EPS Plus Supporting business offers research and development, incubation, production base and other carrier construction and lease management, education and training, and exchange of scientific and educational resources in the academic world. EPS China was founded by December 26, 2008 and is headquartered in Suzhou, China.

Founded in 2013, EPS EKISHIN Co., Ltd. is a subsidiary of EPS Holdings, Inc. that functions as an investment holding Japanese company. The company is based in Tokyo, Japan and specializes in manufacturing and distributing pharmaceuticals and medical equipment.